MapLight Therapeutics News and Activities

Acquisition, funding and merger involving MapLight Therapeutics.

• MapLight Therapeutics has just announced a $227 Million fundraising (posted on October 9 2025).
• MapLight Therapeutics has just announced a $373 Million fundraising (posted on July 30 2025).

View the org chart displaying its 35 main executives

Most searched biographies at MapLight Therapeutics

• Christopher Kroeger, Chief Executive Officer, Founder and Director
• George Pavlov, Director
• Maria Walker, Director

Popular executive movements at MapLight Therapeutics

• Jim Trenkle, Board Member, has left the company  (posted on June 25 2026).
• Robert Malenka, Director, has left the company  (posted on June 25 2026).
• Troy Cox has joined the company as Director  (posted on June 25 2026).

Click here to view some more movements at MapLight Therapeutics

Create your alert
to follow the executive moves at MapLight Therapeutics.

MapLight Therapeutics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by MapLight Therapeutics

• News | MapLight Therapeutics

Social media about MapLight Therapeutics

• MapLight Therapeutics on Wikipedia, Google News & Yahoo Finance
• MapLight Therapeutics on LinkedIn, X (Twitter) & YouTube